Bal Pharma Limited (Bal Pharma), the largest Indian pharmaceutical producer of the bulk drug Gliclazide, an oral hypoglycemic (anti-diabetic drug) claimed victory for the recent imposition of Anti-Dumping Duty imposed by the Indian Ministry of Finance on imports of the bulk substance from China. According to a filing with the Bombay Stock Exchange, Bal Pharma, with manufacturing facilities located in Bangalore, Pune and Uttaranchal, manufactures Gliclazide at its Bangalore facility for both domestic and certain overseas markets.